Detection and Analysis Services for Biomarkers in TME
Relying on the technology platform of the tumor microenvironment center, Alfa Oncology provides a full range of detection and analysis services for biomarkers in TME, and promotes the rapid and efficient completion of projects according to the specific requirements of customers.
Introduction
Tumor markers appear along with tumors and are usually increased in amounts of proteins, oncogenes, tumor suppressor genes and their related products in the form of antigens, enzymes, receptors, hormones or metabolites. It is produced and secreted by tumor cells, or is part of the released tumor cell structure. It exists only in tumor cells and is often released into serum or other body fluids, which can reflect the presence of tumors in the body to a certain extent.
The detection and analysis of tumor biomarkers is the core of personalized and precise tumor therapy, which can determine the occurrence, development and prognosis of tumors. Complete and comprehensive detection is of great significance for elucidating the effect of anti-tumor drugs or drug resistance mechanisms, and screening characteristic populations.
Services
At Alfa Oncology, we have established a mature tumor microenvironment center technology platform, with a professional team and mature technology, as well as years of experience in tumor and microenvironment research. We provide global customers with comprehensive testing services based on ELISA, FACS, pathology and molecular, including Western Blot, Q-PCR, RNAscope and other technical services. It can carry out experiments ranging from protein and mRNA extraction, quantification, molecular sequencing, etc., to support the one-stop research needs of animal model tissue samples, and help you to analyze biomarkers at the molecular dimension.
Service content
| Service type | Specific service content |
| ELISA testing services | Method development and established method validation (Non-GLP) Large and small animal PK sample analysis service ADA/Nab analysis services Biomarker quantitative analysis service |
| FACS inspection services | Receptor occupation (RO) detection service Tumor infiltrating lymphocyte (TIL) detection service |
| Histopathology services | Immunohistochemistry (IHC) services Hematoxylin-eosin staining (HE) service Multicolor immunofluorescence (multi-IF) service RNAscope |
| Molecular testing services | Sanger sequencing RT-PCR/Q-PCR service Genotyping service Molecular typing service Immunotyping service |
Note: Our services list is constantly being updated and improved, please contact us by email for more up-to-date and relevant information.
Our advantages
- Multi-platform qualitative and quantitative detection.
- Customizable methods to meet different needs.
- Guaranteed quality and high method reproducibility.
- Helps you predict or monitor tumor recurrence or changes in the metastatic process.
- Help you diagnose, evaluate treatment effects, predict prognosis, and more.
Service process
Alfa Oncology is dedicated to supporting scientists in making groundbreaking scientific discoveries and developing new applications to accelerate new drug discovery and scientific diagnosis and treatment. We have established the tumor microenvironment center technology platform with high performance scientific instruments and high value solutions to ensure high quality services that enable scientists to explore the mysteries of life at the tumor microenvironment level. Please let us know your project requirements and we will provide you with a comprehensive service from solution to report. If you have any questions, please feel free to contact us.
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.